Product Information
DYANAVEL XR 20 MG TABLET is a brand product labeled by NextWave Pharmaceuticals, Inc, priced at $14.8279 per EA under NDC 24478011001. Its NADAC has been published 171 times since May 17, 2023.
FDA first approved this application on Nov 4, 2021.
Strength
20 mg/1
Manufacturer
NextWave Pharmaceuticals, IncNDC
24478011001
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINEApproval Type
New Drug (NDA)
FDA Application
NDA210526FDA Approved
11/4/2021
On Market Since
11/4/2021
Pharmacological Classes
Price Statistics
The NADAC for DYANAVEL XR 20 MG TABLET has been published 171 times since May 17, 2023, and over the history we have for it it has risen 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.8279 per EA |
|---|---|
| All-time high | $14.8411 (May 13, 2026) |
| All-time low | $13.4870 (May 17, 2023) |
| 52-week high | $14.8411 |
| 52-week low | $14.5454 |
| Median price | $14.2474 |
| Average price | $14.2612 |
| Largest weekly change | +4.7% (Jan 17, 2024) |
| Weeks tracked | 171 |
| Tracking since | May 17, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amphetamine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DYANAVEL XR 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DYANAVEL XR 20 MG TABLET, manufactured by NextWave Pharmaceuticals, Inc, is $14.8279 per EA (NDC 24478011001), effective Aug 19, 2026.
How has the price of DYANAVEL XR 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for DYANAVEL XR 20 MG TABLET has risen 9.9%. It has been tracked across 171 weekly CMS publications since May 17, 2023.
What are the highest and lowest recorded NADAC prices for DYANAVEL XR 20 MG TABLET?
Since May 17, 2023, the NADAC for DYANAVEL XR 20 MG TABLET has ranged from a low of $13.4870 (May 17, 2023) to a high of $14.8411 (May 13, 2026), with a median of $14.2474 per EA.
Are there cheaper alternatives to DYANAVEL XR 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DYANAVEL XR 20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DYANAVEL XR 20 MG TABLET?
DYANAVEL XR 20 MG TABLET (NDC 24478011001) is labeled by NextWave Pharmaceuticals, Inc, and CMS classifies it as a brand product.